Posted on: 11-01-2024
Back to overviewNormec, a leading provider of specialized TICC services, proudly announces the acquisition of Synergy Health Utrecht (“Synergy Health”), a provider of microbiological and chemical testing services in the pharmaceutical and medical device industry. This strategic combination marks an important milestone for Normec, as Synergy Health will represent the first healthcare testing laboratory in the Netherlands, thereby further solidifying the strong ambition of Normec within the wider Healthcare industry and serving life science customers.
Established in 1960, Synergy Health is a leading independent Contract Research Organization, situated in a state-of-the-art, well equipped and unified laboratory in Nieuwegein, the Netherlands. Over the past decades, Synergy Health has grown to become a trustworthy partner for numerous pharmaceutical and medical device companies, offering a comprehensive suite of testing capabilities.
The combination between Normec and Synergy Health is driven by a shared commitment to exceptional customer service, a broad scope of services, and a relentless pursuit of quality. The current and experienced management team remains involved to drive this strategic synergy within the daily operations and innovation of Synergy Health going forward.
Joep Bruins, Founder and CEO of Normec, emphasized: “The acquisition of Synergy Health represents another strategic step for Normec into the healthcare testing industry. We are excited about the expertise and capabilities that Synergy Health brings to our group, allowing us to offer enhanced services and support to pharmaceutical and medical device companies. We are excited about working together with the current management of Synergy Health and look forward to building a shared future”.
Hans Lingeman, Managing Director of Synergy Health: “Another strategic step towards the future with Normec’s Healthcare division: We are ready for further organic growth after a successful relocation and organizational optimizations performed over the last three years. We thank Matthias Stuckmann and René van der Velden from FIELDS for giving the local management team the possibilities and trust to do so. Looking forward to new business opportunities together with the Normec team.”
Matthias Stuckmann, Investment Manager at FIELDS Group: “Synergy Health has gone through a transition over the recent years and we thank Hans Lingeman and his team for the great work which we were able to accomplish together. We were not only able to carve-out successfully two GMP-certified laboratories from its former owner STERIS, but also build a complete new laboratory in Nieuwegein where we combined the operations under one roof. This in combination with a clear strategy on performance improvement and Synergy’s excellent positioning in the healthcare and medical device market have led to an extraordinary company which it is today. We wish Synergy Health and Normec the very best for their joint future.”
Normec were advised on the transaction by KPMG (financial and tax) and Lexence (legal). FIELDS were advised by IMAP (M&A) and Ploum (legal).
About Normec
Normec is an organization primarily active in Western Europe in the field of testing, inspection, certification and compliance (‘TICC’), with a focus on environmental, food, healthcare and life safety markets. Normec started in 2016, with the aim of creating a leading player in the European TICC sector. Our growth has been driven by a combination of successful acquisitions and strong organic growth, and a dedicated focus on professionalizing our combined business operations. As a group of 4,500 people, Normec companies work closely together to gain commercial advantages and strengthen their combined service offerings. For more information, please visit www.normecgroup.com.
About FIELDS Group
FIELDS Group is an entrepreneurial hands-on investor focused on developing companies with potential. FIELDS Group invests in companies with headquarters in Benelux and the DACH region and realizes true transformations with its team.
